Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Propellant Testing in MDIs

Posted on By

SOP for Propellant Testing in MDIs

Propellant Testing Procedures in MDIs

1) Purpose

The purpose of this SOP is to establish procedures for the testing of propellants used in metered-dose inhalers (MDIs) to ensure their quality, safety, and compatibility with product formulations.

2) Scope

This SOP applies to all personnel involved in propellant testing activities within the MDI production facility, including analytical chemists, quality control technicians, and production supervisors.

3) Responsibilities

The responsibilities for this SOP include conducting propellant testing, interpreting test results, documenting findings, and ensuring compliance with specifications. Specific roles include:
Analytical Chemists: Perform analytical testing of propellants using validated methods.
Quality Control Technicians: Verify propellant quality and ensure compatibility with MDI formulations.
Production Supervisors: Review testing outcomes and authorize propellant use based on test results.

See also  SOP for Batch Reconciliation in MDI Production

4) Procedure

4.1 Sample Preparation
4.1.1 Collect representative samples of propellants used in MDIs.
4.1.2 Ensure samples are handled and stored under controlled conditions to maintain integrity.
4.2 Testing Methods
4.2.1 Use validated analytical methods (e.g., gas chromatography) to analyze propellant composition and purity.
4.2.2 Perform testing according to established protocols and acceptance criteria.
4.3 Compatibility Testing
4.3.1 Evaluate propellant compatibility

with MDI formulations through stability and performance testing.
4.3.2 Document test results and assess any interactions or adverse effects observed.
4.4 Documentation
4.4.1 Record propellant testing procedures, including sample collection methods and analytical techniques used.
4.4.2 Document testing results, deviations observed, and any corrective actions taken.

See also  SOP for Handling and Disposal of Waste in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure

6) Documents, if any

Propellant testing protocols, test records, analytical method validations, and batch release certificates should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for propellant testing requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Process Optimization for Powders
Next Post: SOP for Suppository Printer

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version